Wolverine Trading’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-37,300
Closed -$53K 6030
2025
Q2
$53K Buy
37,300
+22,300
+149% +$31.7K ﹤0.01% 4337
2025
Q1
$23.9K Buy
+15,000
New +$23.6K ﹤0.01% 4545
2024
Q4
Sell
-11,200
Closed -$10.6K 5719
2024
Q3
$10.6K Buy
+11,200
New +$14.1K ﹤0.01% 4680
2022
Q1
Sell
-34,000
Closed -$130K 6192
2021
Q4
$130K Buy
34,000
+16,600
+95% +$71.4K ﹤0.01% 4965
2021
Q3
$88K Sell
17,400
-4,600
-21% -$26.5K ﹤0.01% 5834
2021
Q2
$142K Sell
22,000
-9,200
-29% -$64.3K ﹤0.01% 5230
2021
Q1
$210K Sell
31,200
-23,500
-43% -$199K ﹤0.01% 4987
2020
Q4
$544K Buy
54,700
+18,100
+49% +$117K ﹤0.01% 3074
2020
Q3
$130K Sell
36,600
-2,600
-7% -$12.3K ﹤0.01% 4039
2020
Q2
$191K Buy
+39,200
New +$133K ﹤0.01% 3858
2020
Q1
Sell
-106,700
Closed -$587K 5095
2019
Q4
$587K Buy
106,700
+27,400
+35% +$154K ﹤0.01% 2921
2019
Q3
$438K Buy
+79,300
New +$539K ﹤0.01% 2771
2019
Q2
Sell
-64,900
Closed -$341K 4962
2019
Q1
$341K Buy
+64,900
New +$450K ﹤0.01% 3217

Other funds holding PGEN

Wolverine Trading's PGEN Position: Q3 2025 in Review

Wolverine Trading sold out of Precigen (PGEN) in Q3 2025, closing a stake of 27,272 shares — an estimated $38.7K sold.

Wolverine Trading first reported a position in PGEN in Q3 2019 and held it in 12 quarters. The position peaked at $128K in Q4 2021. 167 funds tracked by Wall St. Rank hold PGEN as of Q3 2025.

  • Wolverine Trading reported no remaining Precigen position as of Q3 2025 after selling out during the quarter.
  • Wolverine Trading sold 27,272 Precigen shares in Q3 2025, an estimated $38.7K.
  • Wolverine Trading first reported a position in Precigen in Q3 2019 and held it in 12 quarters.
  • Wolverine Trading's Precigen position peaked at $128K in Q4 2021.
  • 167 funds tracked by Wall St. Rank held Precigen as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.